Senescent bone marrow cells release thrombospondin-1 (Thbs1), which impairs mitochondrial cleanup in immune cells, driving chronic inflammation and blocking bone formation in aging. Blocking this protein restored bone repair in aged animals, identifying a specific therapeutic lever for age-related bone decline.
Key Points
- Thbs1 from aged bone cells suppresses mitochondrial recycling in macrophages.
- This triggers a self-reinforcing inflammatory loop that blocks bone-forming cells.
- Removing Thbs1 restored bone regeneration in aged animal models.
Longevity Analysis
Bone loss accelerates with age due to a conversation between senescent stromal cells and immune cells that becomes pathologically amplified. The mechanism here—impaired mitochondrial quality control leading to redox imbalance and skewed immune polarization—represents a convergence point where multiple aging processes reinforce one another. Rather than treating bone loss directly, this research suggests that interrupting the upstream molecular dialogue that locks both cell types into a dysfunctional state may be more effective. The reversibility shown in animal studies indicates this is not irreversible aging but a treatable signaling malfunction.
Original published by Wiley Aging Cell, by Yifeng Xing, Jingjing Su, Yanjun Lin, Nengwen Huang, Sihui Zhang, Yuwei Zhou, Jie Lu, Weiping Chen, Kaixun He, Wenxiu Yuan, Yang Li, Geyuan Zheng, Pengyuan Hu, Dong Wu, Yanjing Ou, Jiang Chen .